The New Brands & Strategies: Atypical Antipsychotics Report ... - PR Newswire (press release)
Changes in market leadership will continue over the forecast period as four of the five leading atypicals (Risperdal, Zyprexa, Seroquel and Pfizer's Geodon) ...